Circular Genomics and PharmatrophiX Announce Biomarker Collaboration
The collaboration will initially apply blood-based circular RNA profiling to LM11A-31 in Alzheimer’s disease drug development.
The collaboration will initially apply blood-based circular RNA profiling to LM11A-31 in Alzheimer’s disease drug development.